Abstract
The goal of treatment in allergic rhinitis (AR) is to provide effective prevention of or relief from allergic rhinitis symptoms without adversely affecting daily activities or cognitive performance. Effective treatment of allergic rhinitis usually requires an integrated regimen that combines allergen avoidance measures, pharmacotherapy and possible specific- allergen immunotherapy. Oral corticosteroids are very effective but can have unwanted systemic effects. Over the past decade, intranasal corticosteroids have been shown to be the most effective form of pharmacologic treatment for allergic rhinitis. The newer nasal corticosteroids (NCS), offers significant advantages to the patient with AR. They are superior to both antihistamines and cromones and provide topical drug delivery that targets the actions of the drug molecules to the nasal mucosa to minimize the potential for systemic side effects. However, some clinicians remain reluctant to prescribe NCS for children because of their concern for systemic effects, including suppression of growth, of bone metabolism, and of the hypothalamic-pituitary-adrenal (HPA) axis.
Keywords: Allergic rhinitis, pharmacodynamics and pharmacokinetics, nasal corticosteroid, systemic corticosteroids, adverse effects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: The Role of Corticosteroids in Allergic Rhinitis Treatment
Volume: 7 Issue: 1
Author(s): Murat Enoz
Affiliation:
Keywords: Allergic rhinitis, pharmacodynamics and pharmacokinetics, nasal corticosteroid, systemic corticosteroids, adverse effects
Abstract: The goal of treatment in allergic rhinitis (AR) is to provide effective prevention of or relief from allergic rhinitis symptoms without adversely affecting daily activities or cognitive performance. Effective treatment of allergic rhinitis usually requires an integrated regimen that combines allergen avoidance measures, pharmacotherapy and possible specific- allergen immunotherapy. Oral corticosteroids are very effective but can have unwanted systemic effects. Over the past decade, intranasal corticosteroids have been shown to be the most effective form of pharmacologic treatment for allergic rhinitis. The newer nasal corticosteroids (NCS), offers significant advantages to the patient with AR. They are superior to both antihistamines and cromones and provide topical drug delivery that targets the actions of the drug molecules to the nasal mucosa to minimize the potential for systemic side effects. However, some clinicians remain reluctant to prescribe NCS for children because of their concern for systemic effects, including suppression of growth, of bone metabolism, and of the hypothalamic-pituitary-adrenal (HPA) axis.
Export Options
About this article
Cite this article as:
Enoz Murat, The Role of Corticosteroids in Allergic Rhinitis Treatment, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (1) . https://dx.doi.org/10.2174/187152308783769140
DOI https://dx.doi.org/10.2174/187152308783769140 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Vitamin K Oral Anticoagulants (NOACs) A Review of Clinical Management and Laboratory Issues
Current Vascular Pharmacology Is Type D Personality Here to Stay? Emerging Evidence Across Cardiovascular Disease Patient Groups
Current Cardiology Reviews Hypertension in Pregnancy: Clinical Manifestations and Treatment
Current Hypertension Reviews Tyrosine Kinase Inhibitors
Current Cancer Drug Targets Clinical Pharmacology of Novel Anti-Alzheimer Disease Modifying Medications
Current Topics in Medicinal Chemistry The Bioactive Compounds Obtained from Hawthorn, Chokeberry, Rosehip and Bilberry by Microfiltration
Current Bioactive Compounds Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Current Aging Science Effects of Benzodiazepine and Pilocarpine on Rat Parotid Glands: Histomorphometric And Sialometric Study
Medicinal Chemistry Why Not All Hypertensive Patients Are Tachycardic at Rest?
Current Pharmaceutical Design New Treatments for COPD in the Elderly
Current Pharmaceutical Design The Role of Transforming Growth Factor-β in Cardiac Fibrosis
Current Enzyme Inhibition Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments
Current Pharmaceutical Biotechnology Synthesis and Biological Activity of Prostaglandin Analogs Containing Heteroatoms in the Cyclopentane Ring
Current Organic Chemistry Editorial: [Hot Topic: Nanotechnology and Patents in Agriculture, Food Technology, Nutrition and Medicine - Advantages and Risks]
Recent Patents on Food, Nutrition & Agriculture Complement Activation-Related Pseudoallergy Caused by Amphiphilic Drug Carriers: The Role of Lipoproteins
Current Drug Delivery A Review of Diabetes Mellitus and Exposure to the Environmental Toxicant Cadmium with an Emphasis on Likely Mechanisms of Action
Current Diabetes Reviews ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Granulomatous Lung Disease. Disease for Pulmomologists: Diagnosis and Treatment
Current Respiratory Medicine Reviews Exogenous Factors from Venomous and Hematophagous Animals in Drugs and Diagnostic Developments for Cardiovascular and Neurovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Effects of ACE Inhibitors on Skeletal Muscle
Current Pharmaceutical Design